Clinical Trials in Baltimore

Showing 20641-20660 of 23,476 trials

Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects

NCT01918995

This study is to determine the safety, tolerability, and pharmacokinetics of two or three repeat intravenous (IV) bolus doses of regadenoson administered 10 minutes apart in healthy supine subjects.

Healthy Volunteers

Astellas Pharma Global Development, Inc.36 participantsStarted May 2013

Baltimore, Maryland, United States

COMPLETEDPhase 4< 1 mile

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

NCT00948766

The core study assessed the efficacy of a higher dose of rivastigmine 13.3 mg/24 h transdermally (15 cm\^2 patch) compared to a lower dose of the rivastigmine 4.6 mg/24 h transdermally (5 cm\^2 patch) in patients with Severe Dementia of the Alzheimer's Type in a 24-week study. The extension study obtained additional safety and efficacy data, as well as provided the higher dose rivastigmine patch to all patients who completed the core study for an additional 24 weeks.

Alzheimer's Disease

Novartis716 participantsStarted Jul 2009

Tempe, Arizona, United States • Tucson, Arizona, United States • Conway, Arkansas, United States +92 more locations

Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Find Trials by Condition in Baltimore

RNS® System Pivotal Study

Performance of the Hedrocel(R) Cervical Fusion Device

Young Adult Influenza Vaccine Immunogenicity Substudy

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Topical Antifungal Treatment for Tinea Cruris

Safety and Efficacy Study to Treat Bacterial Vaginosis

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia